메뉴 건너뛰기




Volumn 6, Issue 7, 2010, Pages 1155-1162

Approaching Ewing sarcoma

Author keywords

Ewing sarcoma; immunotherapy; target; translation; translocation

Indexed keywords

TRANSCRIPTION FACTOR; RNA BINDING PROTEIN EWS;

EID: 77954685904     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.10.76     Document Type: Review
Times cited : (14)

References (45)
  • 1
    • 0002136462 scopus 로고    scopus 로고
    • Malignant bone tumors
    • United States SEER Program 1975-1999. Ries LAG, Smith MA, Gurney JG, et al. (Eds). National Institutes of Health, Bethesda, MD, USA
    • Gurney JG, Swensen AR, Bulterys M: Malignant bone tumors. In: Cancer Incidence and Survival Among Children and Adolescents. United States SEER Program 1975-1999. Ries LAG, Smith MA, Gurney JG, et al. (Eds). National Institutes of Health, Bethesda, MD, USA, 99-110 (1999).
    • (1999) Cancer Incidence and Survival among Children and Adolescents , pp. 99-110
    • Gurney, J.G.1    Swensen, A.R.2    Bulterys, M.3
  • 2
    • 57449106661 scopus 로고    scopus 로고
    • Ewings tumors over the age of 40: A retrospective analysis of 47 patients treated according to the International Clinical Trials EICESS 92 and EURO-E.W.I.N.G 99
    • Pieper S, Ranft A, Braun-Munzinger G, Jurgens H, Paulussen M, Dirksen U: Ewings tumors over the age of 40: a retrospective analysis of 47 patients treated according to the International Clinical Trials EICESS 92 and EURO-E.W.I.N.G. 99. Onkologie 31(12), 657-663 (2008).
    • (2008) Onkologie , vol.31 , Issue.12 , pp. 657-663
    • Pieper, S.1    Ranft, A.2    Braun-Munzinger, G.3    Jurgens, H.4    Paulussen, M.5    Dirksen, U.6
  • 3
    • 35548935081 scopus 로고    scopus 로고
    • Ewing tumours: Outcome in children, adolescents and adult patients
    • Paulussen M, Ranft A, Dirksen U, Jurgens H: Ewing tumours: outcome in children, adolescents and adult patients. Eur. J. Cancer Suppl. (5), 209-215 (2007).
    • (2007) Eur. J. Cancer Suppl. , vol.5 , pp. 209-215
    • Paulussen, M.1    Ranft, A.2    Dirksen, U.3    Jurgens, H.4
  • 4
    • 52449094980 scopus 로고    scopus 로고
    • Results of the EICESS-92 Study: Two randomized trials of Ewings sarcoma treatment - Cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. European Intergroup Cooperative Ewings Sarcoma Study-92
    • Paulussen M, Craft AW, Lewis I, et al.: Results of the EICESS-92 Study: two randomized trials of Ewings sarcoma treatment - cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. European Intergroup Cooperative Ewings Sarcoma Study-92. J. Clin. Oncol. 26(27), 4385-4393 (2008).
    • (2008) J. Clin. Oncol. , vol.26 , Issue.27 , pp. 4385-4393
    • Paulussen, M.1    Craft, A.W.2    Lewis, I.3
  • 5
    • 66349087641 scopus 로고    scopus 로고
    • Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: A Childrens Oncology Group Study
    • Granowetter L, Womer R, Devidas M, et al.: Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Childrens Oncology Group Study. J. Clin. Oncol. 27(15), 2536-2541 (2009).
    • (2009) J. Clin. Oncol. , vol.27 , Issue.15 , pp. 2536-2541
    • Granowetter, L.1    Womer, R.2    Devidas, M.3
  • 6
    • 75649144053 scopus 로고    scopus 로고
    • The value of local treatment in patients with primary, disseminated multifocal Ewing sarcoma (PDMES)
    • Haeusler J, Ranft A, Bölling T, et al.: The value of local treatment in patients with primary, disseminated multifocal Ewing sarcoma (PDMES). Cancer 116(2), 443-450 (2010).
    • (2010) Cancer , vol.116 , Issue.2 , pp. 443-450
    • Haeusler, J.1    Ranft, A.2    Bölling, T.3
  • 7
    • 48249151771 scopus 로고    scopus 로고
    • Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Childrens Oncology Group. Childrens Oncology Group
    • Leavey PJ, Mascarenhas L, Marina N, et al.: Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: a report from the Childrens Oncology Group. Childrens Oncology Group. Pediatr. Blood Cancer 51(3), 334-338 (2008).
    • (2008) Pediatr. Blood Cancer , vol.51 , Issue.3 , pp. 334-338
    • Leavey, P.J.1    Mascarenhas, L.2    Marina, N.3
  • 8
    • 0027438827 scopus 로고
    • Combinatorial generation of variable fusion proteins in the Ewing family of tumours
    • Zucman J, Melot T, Desmaze C, et al.: Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J. 12(12), 4481-4487 (1993).
    • (1993) EMBO J. , vol.12 , Issue.12 , pp. 4481-4487
    • Zucman, J.1    Melot, T.2    Desmaze, C.3
  • 9
    • 77951630370 scopus 로고    scopus 로고
    • Impact of EWS-ETS fusion type on disease progression in Ewinǵs sarcoma/peripheral primitive neuroectodermal tumor: Prospective results from the cooperative EURO-E.W.I.N.G.99 trial
    • Le Deley MC, Delattre O, Schäfer KL, et al.: Impact of EWS-ETS fusion type on disease progression in Ewinǵs sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative EURO-E.W.I.N.G.99 trial. J. Clin. Oncol 28(12), 1982-1888 (2010).
    • (2010) J. Clin. Oncol , vol.28 , Issue.12 , pp. 1982-1888
    • Le Deley, M.C.1    Delattre, O.2    Schäfer, K.L.3
  • 10
    • 23644447581 scopus 로고    scopus 로고
    • Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma
    • Maksimenko A, Malvy C: Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma. Expert Opin. Ther. Targets 9(4), 825-830 (2005).
    • (2005) Expert Opin. Ther. Targets , vol.9 , Issue.4 , pp. 825-830
    • Maksimenko, A.1    Malvy, C.2
  • 11
    • 70349294051 scopus 로고    scopus 로고
    • Antitumor vectorized oligonucleotides in a model of ewing sarcoma: Unexpected role of nanoparticles
    • Elhamess H, Bertrand JR, Maccario J, Maksimenko A, Malvy C: Antitumor vectorized oligonucleotides in a model of ewing sarcoma: unexpected role of nanoparticles. Oligonucleotides 19(3), 255-264 (2009).
    • (2009) Oligonucleotides , vol.19 , Issue.3 , pp. 255-264
    • Elhamess, H.1    Bertrand, J.R.2    MacCario, J.3    Maksimenko, A.4    Malvy, C.5
  • 12
    • 48249127913 scopus 로고    scopus 로고
    • Microsatellites as EWS/FLI response elements in Ewings sarcoma
    • Gangwal K, Sankar S, Hollenhorst PC, et al.: Microsatellites as EWS/FLI response elements in Ewings sarcoma. Proc. Natl Acad. Sci. USA 105(29), 10149-10154 (2008).
    • (2008) Proc. Natl Acad. Sci. USA , vol.105 , Issue.29 , pp. 10149-10154
    • Gangwal, K.1    Sankar, S.2    Hollenhorst, P.C.3
  • 13
    • 65549090018 scopus 로고    scopus 로고
    • A molecular function map of Ewing̀s sarcoma
    • Kauer M, Nan J, Kofler R, et al.: A molecular function map of Ewing̀s sarcoma. PLoS ONE 4(e5415), 1-11 (2009).
    • (2009) PLoS ONE , vol.4 , Issue.5415 , pp. 1-11
    • Kauer, M.1    Nan, J.2    Kofler, R.3
  • 14
    • 40549086265 scopus 로고    scopus 로고
    • A transcriptional profiling meta-analysis reveals a core EWS-FLI1 gene expression signature
    • Hancock JD, Lessnick SL: A transcriptional profiling meta-analysis reveals a core EWS-FLI1 gene expression signature. Cell Cycle 7(2), 250-256 (2008).
    • (2008) Cell Cycle , vol.7 , Issue.2 , pp. 250-256
    • Hancock, J.D.1    Lessnick, S.L.2
  • 15
    • 65249101694 scopus 로고    scopus 로고
    • EZH2 is a mediator of EWS/Fli1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation
    • Richter GHS, Plehm S, Fasan A, et al.: EZH2 is a mediator of EWS/Fli1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation. PNAS 106(13), 5324-5329 (2009).
    • (2009) PNAS , vol.106 , Issue.13 , pp. 5324-5329
    • Ghs, R.1    Plehm, S.2    Fasan, A.3
  • 16
    • 42049089299 scopus 로고    scopus 로고
    • EWS-Fli1 expression triggers a Ewing sarcoma initiation program in primary human mesenchymal stem cells
    • Riggi N, Suvà ML, Suvà D, et al.: EWS-Fli1 expression triggers a Ewing sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res. 68(7), 2176-2185 (2008).
    • (2008) Cancer Res. , vol.68 , Issue.7 , pp. 2176-2185
    • Riggi, N.1    Suvà, M.L.2    Suvà, D.3
  • 18
    • 70449589299 scopus 로고    scopus 로고
    • GLI1 is a central mediator of EWS/FLI1 signaling in Ewing tumors
    • 10e7608
    • Joo J, Christensen L, Warner K, et al.: GLI1 is a central mediator of EWS/FLI1 signaling in Ewing tumors. PLoS ONE 4(10e7608), 1-9 (2009).
    • (2009) PLoS ONE , vol.4 , pp. 1-9
    • Joo, J.1    Christensen, L.2    Warner, K.3
  • 19
    • 0028170817 scopus 로고
    • Receptor protein-tyrosine kinases and their signal transduction pathways
    • van der Geer P, Hunter T, Lindberg RA: Receptor protein-tyrosine kinases and their signal transduction pathways. Ann. Rev. Cell Biol. 10, 251-337 (1994).
    • (1994) Ann. Rev. Cell Biol. , vol.10 , pp. 251-337
    • Van Der Geer, P.1    Hunter, T.2    Lindberg, R.A.3
  • 20
    • 2342591455 scopus 로고    scopus 로고
    • The discovery of receptor tyrosine kinases: Targets for cancer therapy
    • Gwschind A, Fischer OM, Ullrich A: The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer 4(1), 361-370 (2004). (Pubitemid 38579482)
    • (2004) Nature Reviews Cancer , vol.4 , Issue.5 , pp. 361-370
    • Gschwind, A.1    Fischer, O.M.2    Ullrich, A.3
  • 21
    • 3543026281 scopus 로고    scopus 로고
    • EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3
    • Prieur A, Tirode F, Cohen P, Delattre O: EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol. Cell. Biol. 24(16), 7275-7283 (2004).
    • (2004) Mol. Cell. Biol. , vol.24 , Issue.16 , pp. 7275-7283
    • Prieur, A.1    Tirode, F.2    Cohen, P.3    Delattre, O.4
  • 22
    • 73349099049 scopus 로고    scopus 로고
    • Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1
    • Tolcher AW, Sarantopoulos J, Patnaik A, et al.: Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1. J. Clin. Oncol. 27(34), 5800-5807 (2009).
    • (2009) J. Clin. Oncol. , vol.27 , Issue.34 , pp. 5800-5807
    • Tolcher, A.W.1    Sarantopoulos, J.2    Patnaik, A.3
  • 23
    • 70350227313 scopus 로고    scopus 로고
    • The insulin-like growth factor-1 receptor-targeting antibody, CP-751, 871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma
    • Kurmasheva RT, Dudkin L, Billups C, Debelenko LV, Morton CL, Houghton PJ: The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma. Cancer Res. 69(19), 7662-7671 (2009).
    • (2009) Cancer Res. , vol.69 , Issue.19 , pp. 7662-7671
    • Kurmasheva, R.T.1    Dudkin, L.2    Billups, C.3    Debelenko, L.V.4    Morton, C.L.5    Houghton, P.J.6
  • 24
    • 67650302850 scopus 로고    scopus 로고
    • Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a Bayesian hierarchical statistical model
    • Chugh R, Wathen KJ, Maki RG, et al.: Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a Bayesian hierarchical statistical model. J. Clin. Oncol. 27(7), 3148-3153 (2009).
    • (2009) J. Clin. Oncol. , vol.27 , Issue.7 , pp. 3148-3153
    • Chugh, R.1    Wathen, K.J.2    Maki, R.G.3
  • 25
    • 33847348574 scopus 로고    scopus 로고
    • Protein expression of KIT and gene mutation of c-Kit and PDGFRs in Ewing sarcomas
    • Do I, Araujo ES, Kalil RK, et al.: Protein expression of KIT and gene mutation of c-Kit and PDGFRs in Ewing sarcomas. Pathol. Res. Pract. 203(1), 486-492 (2007).
    • (2007) Pathol. Res. Pract. , vol.203 , Issue.1 , pp. 486-492
    • Do, I.1    Araujo, E.S.2    Kalil, R.K.3
  • 26
    • 77949740524 scopus 로고    scopus 로고
    • ABT-869 inhibits the proliferation of Ewing sarcoma cells and suppresses platelet-derived growth factor receptor b and c-KIT signalling pathways
    • Ikeda AK, Judelson DR, Federman N, et al.: ABT-869 inhibits the proliferation of Ewing sarcoma cells and suppresses platelet-derived growth factor receptor b and c-KIT signalling pathways. Mol. Cancer Ther. 9(3), 653-660 (2010).
    • (2010) Mol. Cancer Ther. , vol.9 , Issue.3 , pp. 653-660
    • Ikeda, A.K.1    Judelson, D.R.2    Federman, N.3
  • 27
    • 32044465506 scopus 로고    scopus 로고
    • TOR signalling in growth and metabolism
    • Wullschleger S, Loewith R, Hall MN: TOR signalling in growth and metabolism. Cell 124(3), 471-484 (2006).
    • (2006) Cell , vol.124 , Issue.3 , pp. 471-484
    • Wullschleger, S.1    Loewith, R.2    Hall, M.N.3
  • 28
    • 1642540093 scopus 로고    scopus 로고
    • Rapamycin induces the fusion-type independent downregulation of the EWS-Fli1 proteins and inhibits Ewings sarcoma cell proliferation
    • Mateo-Lozano, S, Tirado OM, Notario V: Rapamycin induces the fusion-type independent downregulation of the EWS-Fli1 proteins and inhibits Ewings sarcoma cell proliferation. Oncogene 22(3), 9282-9287 (2003).
    • (2003) Oncogene , vol.22 , Issue.3 , pp. 9282-9287
    • Mateo-Lozano, S.1    Tirado, O.M.2    Notario, V.3
  • 29
    • 67650447477 scopus 로고    scopus 로고
    • A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewings sarcoma
    • Erkizan HV, Kong Y, Merchant M, et al.: A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewings sarcoma. Nat. Med. 15(7), 750-756 (2009).
    • (2009) Nat. Med. , vol.15 , Issue.7 , pp. 750-756
    • Erkizan, H.V.1    Kong, Y.2    Merchant, M.3
  • 30
    • 38549084557 scopus 로고    scopus 로고
    • Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing̀s sarcoma family of tumors
    • Roberts P, Burchill SA, Brownhill S, et al.: Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing̀s sarcoma family of tumors. Genes Chromosomes Cancer 47(4), 207-220 (2007).
    • (2007) Genes Chromosomes Cancer , vol.47 , Issue.4 , pp. 207-220
    • Roberts, P.1    Burchill, S.A.2    Brownhill, S.3
  • 31
    • 70349753195 scopus 로고    scopus 로고
    • Advances in Ewing̀s sarcoma research: Where are we now and what lies ahead?
    • Ordonez JL, Osuna D, Herrero D, de Alava E, Madoz-Gurpide J: Advances in Ewing̀s sarcoma research: where are we now and what lies ahead? Cancer Res. 69(18), 7140-7150 (2009).
    • (2009) Cancer Res. , vol.69 , Issue.18 , pp. 7140-7150
    • Ordonez, J.L.1    Osuna, D.2    Herrero, D.3    De Alava, E.4    Madoz-Gurpide, J.5
  • 32
    • 66849124862 scopus 로고    scopus 로고
    • Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: Implications for immune recognition
    • Berghuis D, de Hooge AS, Santos SJ, et al.: Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition. J. Pathol. 218(2), 222-231 (2009).
    • (2009) J. Pathol. , vol.218 , Issue.2 , pp. 222-231
    • Berghuis, D.1    De Hooge, A.S.2    Santos, S.J.3
  • 33
    • 67650091383 scopus 로고    scopus 로고
    • A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25(hi) FoxP3+) in Ewing sarcoma patients is associated with metastatic disease
    • Brinkrolf P, Landmeier S, Altvater B, et al.: A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25(hi) FoxP3+) in Ewing sarcoma patients is associated with metastatic disease. Int. J. Cancer 125(4), 879-886 (2009).
    • (2009) Int. J. Cancer , vol.125 , Issue.4 , pp. 879-886
    • Brinkrolf, P.1    Landmeier, S.2    Altvater, B.3
  • 34
    • 77954675158 scopus 로고    scopus 로고
    • NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways
    • Verhoeven DH, de Hooge AS, Mooiman EC, et al.: NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways. Pediatr. Transplant. 13(6), 746-753 (2008).
    • (2008) Pediatr. Transplant. , vol.13 , Issue.6 , pp. 746-753
    • Verhoeven, D.H.1    De Hooge, A.S.2    Mooiman, E.C.3
  • 35
    • 51049105734 scopus 로고    scopus 로고
    • A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas
    • Macall CL, Rhea EH, Read EJ, et al.: A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas. Clin. Cancer Res. 14(15), 4850-4880 (2008).
    • (2008) Clin. Cancer Res. , vol.14 , Issue.15 , pp. 4850-4880
    • MacAll, C.L.1    Rhea, E.H.2    Read, E.J.3
  • 36
    • 34447295403 scopus 로고    scopus 로고
    • Interferon g sensitizes resistant Ewings sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity
    • Lissat A, Vraetz T, Tsokos M, et al.: Interferon g sensitizes resistant Ewings sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity. Am. J. Pathol. 170, 1917-1930 (2007).
    • (2007) Am. J. Pathol. , vol.170 , pp. 1917-1930
    • Lissat, A.1    Vraetz, T.2    Tsokos, M.3
  • 37
    • 0037565276 scopus 로고    scopus 로고
    • TRAIL-induced apoptosis and interaction with cyctotoxic agents in soft tissue sarcoma cell lines
    • Tomek S, Koestler W, Horak P, et al.: TRAIL-induced apoptosis and interaction with cyctotoxic agents in soft tissue sarcoma cell lines. Eur. J. Cancer 39(2), 1318-1329 (2003).
    • (2003) Eur. J. Cancer , vol.39 , Issue.2 , pp. 1318-1329
    • Tomek, S.1    Koestler, W.2    Horak, P.3
  • 38
    • 54249107246 scopus 로고    scopus 로고
    • The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway
    • Wang S: The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway. Oncogene 27(3), 6297-16215 (2008).
    • (2008) Oncogene , vol.27 , Issue.3 , pp. 6297-16215
    • Wang, S.1
  • 39
    • 29144462140 scopus 로고    scopus 로고
    • Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewings sarcoma
    • Scotlandi K, Perdichizzi S, Bernard G, et al.: Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewings sarcoma. Eur. J. Cancer 42(1), 91-96 (2006).
    • (2006) Eur. J. Cancer , vol.42 , Issue.1 , pp. 91-96
    • Scotlandi, K.1    Perdichizzi, S.2    Bernard, G.3
  • 40
    • 0031045193 scopus 로고    scopus 로고
    • Interethnic polymorphism of EWS intron 6: Menome plasticity mediated by Alu reposition and recombination
    • Zucman-Rossi J, Batzer MA, Stoneking M, et al.: Interethnic polymorphism of EWS intron 6: menome plasticity mediated by Alu reposition and recombination. Hum. Genet. 99, 357-363 (1997).
    • (1997) Hum. Genet. , vol.99 , pp. 357-363
    • Zucman-Rossi, J.1    Batzer, M.A.2    Stoneking, M.3
  • 41
    • 76249093091 scopus 로고    scopus 로고
    • Ethnic and racial differences in patients with Ewing sarcoma
    • Worch J, Matthay KK, Neuhaus J, Goldsby R, DuBois SG: Ethnic and racial differences in patients with Ewing sarcoma. Cancer 2(15), 983-988 (2010).
    • (2010) Cancer , vol.2 , Issue.15 , pp. 983-988
    • Worch, J.1    Matthay, K.K.2    Neuhaus, J.3    Goldsby, R.4    Dubois, S.G.5
  • 42
    • 68149164796 scopus 로고    scopus 로고
    • Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome
    • Jawad MU, Cheung MC, Min ES, Schneiderbauer MM, Koniaris LG, Scully SP: Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome. Cancer 115(15), 3526-3536 (2009).
    • (2009) Cancer , vol.115 , Issue.15 , pp. 3526-3536
    • Jawad, M.U.1    Cheung, M.C.2    Min, E.S.3    Schneiderbauer, M.M.4    Koniaris, L.G.5    Scully, S.P.6
  • 43
    • 17444447915 scopus 로고    scopus 로고
    • Prognostic factors in nonmetastatic Ewings sarcoma of bone treated with adjuvant chemotherapy: Analysis of 359 patients at the Istituto Ortopedico Rizzoli
    • Bacci G, Ferrari S, Bertoni F, et al.: Prognostic factors in nonmetastatic Ewings sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. J. Clin. Oncol. 18(1), 4-11 (2000).
    • (2000) J. Clin. Oncol. , vol.18 , Issue.1 , pp. 4-11
    • Bacci, G.1    Ferrari, S.2    Bertoni, F.3
  • 44
    • 0002550752 scopus 로고
    • Improvement in survival for Ewing̀s sarcoma by substitution of ifosfamide for cyclophosphamide: A UKCCSG/MRC study
    • Craft AW, Cotterill S, Imeson J: Improvement in survival for Ewing̀s sarcoma by substitution of ifosfamide for cyclophosphamide: a UKCCSG/MRC study. Am. J. Pediatr. Hematol. Oncol. 15(1), 31-35 (1993).
    • (1993) Am. J. Pediatr. Hematol. Oncol. , vol.15 , Issue.1 , pp. 31-35
    • Craft, A.W.1    Cotterill, S.2    Imeson, J.3
  • 45
    • 7144261049 scopus 로고    scopus 로고
    • Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies
    • Paulussen M, Ahrens S, Burdach S, et al.: Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Ann. Oncol. 9, 275-281 (1998).
    • (1998) Ann. Oncol. , vol.9 , pp. 275-281
    • Paulussen, M.1    Ahrens, S.2    Burdach, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.